VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Trends Analyst Outlook Journalist POV

49 hedge funds and large institutions have $579M invested in VYNE Therapeutics in 2018 Q1 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$151M
2
+$76.8M
3
+$60.1M
4
VP
venBio Partners
California
+$54.9M
5
NHAS
Novo Holdings A/S
Denmark
+$51.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$682K
27
$540K
28
$535K
29
$481K
30
$469K
31
$448K
32
$368K
33
$310K
34
$304K
35
$192K
36
$154K
37
$132K
38
$67K
39
$50K
40
$43.3K
41
$43K
42
$38K
43
$32K
44
$20K
45
$18K
46
$14K
47
$9K
48
$7K
49
$2K
1
2